Canada - English - Health Canada

mantra pharma inc - teriflunomide - tablet - 14mg - teriflunomide 14mg

Israel - English - Ministry of Health

taro international ltd, israel - teriflunomide - film coated tablets - teriflunomide 14 mg - teriflunomide - for the treatment of adult patients with relapsing remitting forms of multiple sclerosis (ms) ) to reduce the frequency of clinical relapses and to delay the progression of physical disability.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - teriflunomide, quantity: 14 mg - tablet, film coated - excipient ingredients: hypromellose; purified water; magnesium stearate; lactose monohydrate; titanium dioxide; purified talc; hyprolose; brilliant blue fcf aluminium lake; colloidal anhydrous silica; microcrystalline cellulose; indigo carmine aluminium lake; glycerol; allura red ac aluminium lake; maize starch; sodium starch glycollate type a - for the treatment of patients with relapsing forms of multiple sclerosis to reduce the frequency of clinical relapses and to delay the progression of physical disability.

United States - English - NLM (National Library of Medicine)

zydus lifesciences limited - teriflunomide (unii: 1c058ikg3b) (teriflunomide - unii:1c058ikg3b) -

Australia - English - Department of Health (Therapeutic Goods Administration)

alembic pharmaceuticals australia pty ltd - teriflunomide, quantity: 14 mg - tablet, film coated - excipient ingredients: lactose monohydrate; maize starch; sodium starch glycollate type a; colloidal anhydrous silica; magnesium stearate; purified water; microcrystalline cellulose; hyprolose; titanium dioxide; hypromellose; indigo carmine aluminium lake; macrogol 8000; purified talc - terilembic teriflunomide is indicated for the treatment of patients with relapsing forms of multiple sclerosis to reduce the frequency of clinical relapses and to delay the progression of physical disability

Israel - English - Ministry of Health

medomie pharma ltd, israel - teriflunomide - film coated tablets - teriflunomide 14 mg - teriflunomide - teriflunomide medomie is indicated for the treatment of adult patients with relapsing remitting forms of multiple sclerosis (ms) to reduce the frequency of clinical relapses and to delay the progression of physical disability.

Malta - English - Medicines Authority

msn labs europe limited kw20a, corradino park, paola pla 3000, malta - film-coated tablet - teriflunomide 14 mg - immunosuppressants

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - teriflunomide -

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - teriflunomide -

Malta - English - Medicines Authority

torrent pharma (malta) limited central business centre, level 2, triq hal tarxien, gudja, gdj 1907, malta - film-coated tablet - teriflunomide 14 mg - immunosuppressants